163 related articles for article (PubMed ID: 28661203)
1. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: not FIT for purpose?
Quyn AJ; Steele RJ; Digby J; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Fraser CG
Ann Clin Biochem; 2018 Jan; 55(1):69-76. PubMed ID: 28661203
[TBL] [Abstract][Full Text] [Related]
2. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J
BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225
[TBL] [Abstract][Full Text] [Related]
3. The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer.
Turvill JL; Turnock D; Cottingham D; Haritakis M; Jeffery L; Girdwood A; Hearfield T; Mitchell A; Keding A
Br J Gen Pract; 2021 Aug; 71(709):e643-e651. PubMed ID: 33798091
[TBL] [Abstract][Full Text] [Related]
4. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
5. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
[TBL] [Abstract][Full Text] [Related]
6. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
[TBL] [Abstract][Full Text] [Related]
7. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
8. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.
Westwood M; Lang S; Armstrong N; van Turenhout S; Cubiella J; Stirk L; Ramos IC; Luyendijk M; Zaim R; Kleijnen J; Fraser CG
BMC Med; 2017 Oct; 15(1):189. PubMed ID: 29061126
[TBL] [Abstract][Full Text] [Related]
9. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
10. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
[TBL] [Abstract][Full Text] [Related]
11. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
12. Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
Farrugia A; Widlak M; Evans C; Smith SC; Arasaradnam R
Frontline Gastroenterol; 2020 Jan; 11(1):28-33. PubMed ID: 31885837
[TBL] [Abstract][Full Text] [Related]
13. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
[TBL] [Abstract][Full Text] [Related]
14. Low faecal haemoglobin concentration potentially rules out significant colorectal disease.
McDonald PJ; Digby J; Innes C; Strachan JA; Carey FA; Steele RJ; Fraser CG
Colorectal Dis; 2013 Mar; 15(3):e151-9. PubMed ID: 23199241
[TBL] [Abstract][Full Text] [Related]
15. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
[TBL] [Abstract][Full Text] [Related]
16. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
[TBL] [Abstract][Full Text] [Related]
17. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population.
Bailey JA; Ibrahim H; Bunce J; Chapman CJ; Morling JR; Simpson JA; Humes DJ; Banerjea A
Tech Coloproctol; 2021 Oct; 25(10):1151-1154. PubMed ID: 34263362
[TBL] [Abstract][Full Text] [Related]
18. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
[TBL] [Abstract][Full Text] [Related]
19. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
[TBL] [Abstract][Full Text] [Related]
20. Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study.
Elias SG; Kok L; de Wit NJ; Witteman BJ; Goedhard JG; Romberg-Camps MJ; Muris JW; Moons KG
BMC Med; 2016 Sep; 14(1):141. PubMed ID: 27666114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
